Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01166009 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CIBMTR Research Database

StatusRecruiting
PhaseNot specified
Started2002-07
View on ClinicalTrials.gov ↗

Amendment history

2025-08-07
Study Identification, Study Status, Contacts/Locations v18
Primary completion date2025-07→2050-07
Completion date2030-07→2050-07
2025-01-29
Study Identification, Study Status, Oversight, IPDSharing v17
Re-verified, no change to tracked fields
2024-02-22
Study Status v16
Completion date2025-07→2030-07
2023-01-20
Study Status, Conditions, Outcome Measures, Eligibility, Contacts/Locations v15
Study sites1→2
2022-03-18
Study Identification, Study Status, Outcome Measures v14
Secondary endpoints1 to 3 entries
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients with Medicare Coverage (17-CMS-SCD) Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients with Medicare Coverage (10CMSMDS-1)
Study title-104 characters
Protocol For ACIBMTR Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
Show 13 earlier versions
2021-12-08
Study Status, Contacts/Locations v13
Study sitescontacts updated at 1 of 1 site
2021-01-28
Study Status, Contacts/Locations v12
Study sitescontacts updated at 1 of 1 site
2019-07-22
Study Status, Study Description, Study Design, Contacts/Locations v11
Primary completion date2020-07→2025-07
Completion date2020-07→2025-07
2018-04-20
4 amendments v7-v10
4 re-verifications since 2016-10-24, no change to tracked fields
2015-02-02
Study Status v6
Completion datenot stated→2020-07
2014-05-01
Study Status, Contacts/Locations v5
Re-verified, no change to tracked fields
2013-09-18
Study Identification, Study Status, Study Design v4
Study title+48 characters
Protocol For A Research Database Study forFor Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
2013-09-06
Study Status v3
Primary completion datenot stated→2020-07
2013-03-06
2 amendments v1-v2
2 re-verifications since 2012-07-05, no change to tracked fields
2010-07-19
Original filing
The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study HSC transplantation and cellular therapies. A secondary purpose of the Research Database is to have a comprehensive source of data to study marrow toxic injuries. Objectives: To learn more about what makes stem cell transplants and cellular therapies work well such as: * Determine how well recipients recover from their transplants or cellular therapy; * Determine how recovery after a transplant or cellular therapy can be improved; * Determine how a donor's or recipient's genetics impact recipient recovery after a transplant or cellular therapy; * Determine how access to transplant or cellular therapy for different groups of patients can be improved; * Determine how well donors recover from the collection procedures.
Trial Details
NCT Number NCT01166009
Lead Sponsor Center for International Blood and Marrow Transplant Research
Conditions Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Solid Tumors, Blood Cancers, CAR-T, Gene Therapy, Non-malignant Disease
Enrollment 99,999,999 participants
Start Date 2002-07
Primary Completion 2050-07 (estimated)
Study Completion 2050-07 (estimated)
Updated on ClinicalTrials.gov 2025-08-12